Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Heterozygous gain-of-function variants in FGFR1 have been implicated in Jackson-Weiss syndrome, an autosomal dominant craniosynostosis and foot malformation disorder. A patient presenting with brachydactyly and broad halluces was found to carry an activating c.755C>G (p.Pro252Arg) substitution in the IgII–III linker of FGFR1, recapitulating molecular changes seen in other FGFR-related craniosynostoses (PMID:10861678). No additional unrelated cases or familial segregation have been reported to date.
Functional characterization of the Pro252Arg mutant receptor demonstrated enhanced affinity for FGF ligands and formation of additional receptor–ligand hydrogen bonds, as shown by surface plasmon resonance and X-ray crystallography. These mechanistic data, analogous to those reported for Pro→Arg mutations in FGFR2 and FGFR3, support a gain-of-function pathogenic mechanism in Jackson-Weiss syndrome (PMID:14613973).
Gene–Disease AssociationLimitedSingle unrelated proband with c.755C>G (p.Pro252Arg) variant in FGFR1 and consistent phenotype ([PMID:10861678]) Genetic EvidenceLimitedOne proband, no familial segregation data Functional EvidenceModerateBiophysical and structural studies demonstrate gain-of-function by enhanced ligand binding and new receptor–ligand contacts ([PMID:14613973]) |